Skip to main content
Back to Temasek Holdings

Temasek Holdings's Life Science Portfolio

Browse 4 Life Science companies funded by Temasek Holdings. See funding amounts, founder contacts, and investment details.

Life Science Companies
4
Total Funding in Life Science
$202.9M

Life Science Portfolio Companies (4)

Export
Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

London, United Kingdom
May 2026
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyForestryLife ScienceNatural Resources

Living Carbon is a public benefit company on a mission to fight climate change by genetically enhancing CO2 capture and storage in trees.

San Francisco, United States
April 2026
$21.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Cambridge, United States
March 2025
$73.9M
Series C

Founder Contacts

19,000+ verified contacts

Explore Temasek Holdings's Full Portfolio

View all companies funded by Temasek Holdings across every industry and funding stage.

View Full Temasek Holdings Portfolio